Viewing Study NCT02454634


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2026-02-26 @ 11:43 PM
Study NCT ID: NCT02454634
Status: COMPLETED
Last Update Posted: 2018-11-07
First Post: 2015-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas
Sponsor: National Center for Tumor Diseases, Heidelberg
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IDH1R132H View
None peptide vaccine View
None immunotherapy View
None IDH1R132H-mutated glioma View